PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Motherwort injection, alone or combined with oxytocin, is used to prevent PPH after vaginal delivery, cesarean section, and induced abortion [PMID:29882344, PMID:31354850, PMID:35935833, PMID:40527062].
Add-on therapy of motherwort injection to carboprost tromethamine significantly reduced post-partum blood loss at 2h and 24h [PMID:30288846].
Intravenous administration of motherwort (Leonurus Heterophyllus Sweet) showed improvement in hemorheology, decreasing blood viscosity and fibrinogen volume [PMID:2589238].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 23042598 (2013) — Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology. · Phytotherapy research : PTR
- 2.PMID: 40527062 (2025) — Motherwort synergized with oxytocin for postpartum hemorrhage prevention: Integrated clinical efficacy and mechanism exploration. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 33503956 (2021) — Phytochemical and Psychotropic Research of Motherwort (Leonurus cardiaca L.) Modified Dry Extracts. · Plants (Basel, Switzerland)
- 4.PMID: 35935833 (2022) — Motherwort Injection for Preventing Uterine Hemorrhage in Women With Induced Abortion: A Systematic Review and Meta-Analysis of Randomized Evidence. · Frontiers in pharmacology
- 5.PMID: 29882344 (2018) — Motherwort injection for preventing postpartum hemorrhage in pregnant women with cesarean section: A systematic review and meta-analysis.